Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

计划入组 38 人 · 首次发布于 2016 年 3 月 24 日

A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization

计划入组 110 人 · 首次发布于 2015 年 8 月 27 日

A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children

计划入组 600 人 · 首次发布于 2015 年 9 月 14 日

rVSVN4CT1-EBOVGP1

Ebola Zaire vaccine (live, attenuated)(Zabdeno)

Ebola virus vaccine (Profectus Biosciences)

AIM VACCINE

China

Finlay Vaccine Institute

Path Vaccine Solutions

United States

SK Bioscience Partners with MSD and Hilleman Labs on $30M CEPI-Funded Zaire Ebola Vaccine Development

CEPI Launches Two Major Initiatives to Accelerate Vaccine Development and Regulatory Approval in Disease Outbreaks

Ebola and Hantavirus: What Clinicians Need to Know About These Deadly Infectious Diseases